Methods for concomitant administration of colchicine and a second active agent
View Patent ↗Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided.
1. A method of treating a patient in need of treatment for Familial Mediterranean Fever with colchicine, comprising
orally administering to the patient in need of treatment for Familial Mediterranean Fever, an adjusted daily dosage amount of colchicine wherein the patient is receiving concomitant administration of 200 mg per day of ritonavir,
wherein the adjusted daily dosage amount of colchicine is a maximum colchicine dosage amount of 0.6 mg of colchicine per day which is a reduction from an intended daily dosage amount of colchicine in the absence of concomitant ritonavir as follows:
Daily dosage amount
Age
Usual
Maximum
Adults and children >12 years
1.2 mg
2.4 mg
Children >6 to 12 years
0.9 mg
1.8 mg
Children 4 to 6 years
0.3 mg
1.8 mg